Cargando…

Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice

Gut microbiota plays a significant role in the development of hepatocellular carcinoma (HCC) in non-alcoholic steatohepatitis (NASH). However, understanding of the precise mechanism of this process remains incomplete. A new class steatohepatitis-inducing high-fat diet (HFD), namely STHD-01, can prom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamada, Shoji, Takashina, Yoko, Watanabe, Mitsuhiro, Nagamine, Ryogo, Saito, Yoshimasa, Kamada, Nobuhiko, Saito, Hidetsugu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839411/ https://www.ncbi.nlm.nih.gov/pubmed/29515780 http://dx.doi.org/10.18632/oncotarget.24066

Ejemplares similares

Gut microbiota-mediated generation of saturated fatty acids elicits inflammation in the liver in murine high-fat diet-induced steatohepatitis
por: Yamada, Shoji, et al.
Publicado: (2017)

Nrf2-mediated anti-oxidant effects contribute to suppression of non-alcoholic steatohepatitis-associated hepatocellular carcinoma in murine model
por: Yamada, Shoji, et al.
Publicado: (2018)

Silencing of microRNA-122 is an early event during hepatocarcinogenesis from non-alcoholic steatohepatitis
por: Takaki, Yoko, et al.
Publicado: (2014)

Impact of Vancomycin Treatment and Gut Microbiota on Bile Acid Metabolism and the Development of Non-Alcoholic Steatohepatitis in Mice
por: Kasai, Kaichi, et al.
Publicado: (2023)

Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis
por: Liakina, Valentina, et al.
Publicado: (2022)

Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism
por: Lei, Yuanyuan, et al.
Publicado: (2022)

Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut–Liver Axis
por: Yang, Chao, et al.
Publicado: (2021)

Lactiplantibacillus plantarum LPJZ-658 Improves Non-Alcoholic Steatohepatitis by Modulating Bile Acid Metabolism and Gut Microbiota in Mice
por: Liu, Liming, et al.
Publicado: (2023)

Contribution of the Gut Microbiota to Intestinal Fibrosis in Crohn's Disease
por: Watanabe, Daisuke, et al.
Publicado: (2022)

microRNA-mediated resistance to hypoglycemia in the HepG2 human hepatoma cell line
por: Ueki, Satomi, et al.
Publicado: (2016)

Rifaximin Ameliorates Non-alcoholic Steatohepatitis in Mice Through Regulating gut Microbiome-Related Bile Acids
por: Jian, Jie, et al.
Publicado: (2022)

Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
por: Gillard, Justine, et al.
Publicado: (2021)

Geniposide plus chlorogenic acid reverses non-alcoholic steatohepatitis via regulation of gut microbiota and bile acid signaling in a mouse model in vivo
por: Li, Hongshan, et al.
Publicado: (2023)

Dietary soybean protein ameliorates high-fat diet-induced obesity by modifying the gut microbiota-dependent biotransformation of bile acids
por: Watanabe, Keita, et al.
Publicado: (2018)

MicroRNAs in cancers and neurodegenerative disorders
por: Saito, Yoshimasa, et al.
Publicado: (2012)

Role of CTCF in the regulation of microRNA expression
por: Saito, Yoshimasa, et al.
Publicado: (2012)

The Association of Gut Microbiota with Nonalcoholic Steatohepatitis in Thais
por: Sobhonslidsuk, Abhasnee, et al.
Publicado: (2018)

Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
por: Rios, Rafael S., et al.
Publicado: (2021)

Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development
por: Mouries, Juliette, et al.
Publicado: (2019)

Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites
por: Zhu, Mingzhe, et al.
Publicado: (2023)

Pathogenic role of the gut microbiota in gastrointestinal diseases
por: Nagao-Kitamoto, Hiroko, et al.
Publicado: (2016)

microRNA-34a as a Therapeutic Agent against Human Cancer
por: Saito, Yoshimasa, et al.
Publicado: (2015)

Aberrant DNA Methylation as a Biomarker and a Therapeutic Target of Cholangiocarcinoma
por: Nakaoka, Toshiaki, et al.
Publicado: (2017)

Establishment and Long-Term Culture of Organoids Derived from Human Biliary Tract Carcinoma
por: Saito, Yoshimasa, et al.
Publicado: (2020)

Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
por: Shu, Xiangbing, et al.
Publicado: (2021)

Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma
por: Ramai, Daryl, et al.
Publicado: (2021)

Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis
por: Tovo, Cristiane Valle, et al.
Publicado: (2023)

Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma
por: Yu, Junjie, et al.
Publicado: (2023)

Obesity and non-alcoholic steatohepatitis in immunotherapy for hepatocellular carcinoma
por: Shiina, Shuichiro, et al.
Publicado: (2023)

Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma
por: Kumar, Rahul, et al.
Publicado: (2020)

Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis
por: Luo, Yi, et al.
Publicado: (2021)

Val‐Val‐Tyr‐Pro protects against non‐alcoholic steatohepatitis in mice by modulating the gut microbiota and gut‐liver axis activation
por: Xie, Xinshu, et al.
Publicado: (2021)

Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma: Implications for Lycopene Intervention
por: Ip, Blanche C., et al.
Publicado: (2013)

Fatty Acid Elongation in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
por: Kessler, Sonja M., et al.
Publicado: (2014)

Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma
por: Weinmann, Arndt, et al.
Publicado: (2015)

The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease
por: Ni, Yiming, et al.
Publicado: (2022)

Metabolism of Cholesterol and Bile Acids by the Gut Microbiota
por: Gérard, Philippe
Publicado: (2013)

Bile acids, gut microbiota and metabolic surgery
por: Tu, Jui, et al.
Publicado: (2022)

Statistical physics
por: Toda, Morikazu, et al.
Publicado: (1983)

A Case of Hypopituitarism Complicated by Non-Alcoholic Steatohepatitis and Severe Pulmonary Hypertension
por: Suzuki, Keiko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6i99hopdqdrp3257ptrr1enrj2